1. Unilever expects input costs to be passed on to end consumer
Unilever announced a new €3bn share buyback and said it does not intend to pursue any more acquisitions in the foreseeable future, following the failed bid for GlaxoSmithKline’s consumer healthcare business last month.
2. Strong Disney earnings boosts shares
The Walt Disney Company (NYSE:DIS) shares jumped in after-market trading following forecast-busting earnings as consumers gave their mark of approval on its streaming offering.
3. Five AstraZeneca drugs are ‘blockbuster’
AstraZeneca said five new drugs had taken on blockbuster status last year generating over US$1bn in revenues each as it delivered a strong financial performance, boosted by the US$39bn takeover of Alexion Pharmaceuticals.
4. FTSE 100 closes ahead
Britain's blue-chip index finished the afternoon session at 7,672, up around 28 points, or 0.38% with resource stocks among the top gainers.
5. TB screening 'huge scalable opportunity' for Feedback
Feedback PLC (AIM:FDBK) provided updates on the main two ongoing areas of focus for its Bleepa platform in year ahead: technology opportunities with the NHS and tuberculosis (TB) testing in India.
More on tomorrow's news
Announcements from British American Tobacco, Tate and Lyle, Victrex and many more...